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In Brief
Soro-Arnaiz et al. identify an age-
dependent mitochondrial CIV
dysfunction in white adipocytes involving
HIF1A-dependent repression of CIV
subunits such as Cox5b. Silencing Cox5b
promotes white adipocyte enlargement in
young mice, whereas its restoration
prevents age-dependent obesity.
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Aging is associated with progressive white
adipose tissue (WAT) enlargement initiated early
in life, but the molecular mechanisms involved
remain unknown. Here we show that mitochondrial
complex IV (CIV) activity and assembly are
already repressed in white adipocytes of middle-
aged mice and involve a HIF1A-dependent decline
of essential CIV components such as COX5B. At
the molecular level, HIF1A binds to the Cox5b
proximal promoter and represses its expression.
Silencing of Cox5b decreased fatty acid oxidation
and promoted intracellular lipid accumulation.
Moreover, local in vivo Cox5b silencing in WAT of
young mice increased the size of adipocytes,
whereas restoration of COX5B expression in
aging mice counteracted adipocyte enlargement.
An age-dependent reduction in COX5B gene
expression was also found in human visceral adi-
pose tissue. Collectively, our findings establish a
pivotal role for CIV dysfunction in progressive
white adipocyte enlargement during aging, which
can be restored to alleviate age-dependent WAT
expansion.Cell Repo
This is an open access article under the CC BY-NINTRODUCTION
With a steadily increasing incidence, obesity has become the
leading medical disorder of the 21st Century. In particular, the
middle-aged population appears to be prone to obesity (Ng
et al., 2014; Ogden et al., 2013; van Harmelen et al., 2003).
Although the reasons for this remain largely enigmatic, several
factors are strongly implicated in the development of obesity,
such as sedentary lifestyle and poor dietary habits. Genetic
factors have also been suggested to control age-dependent
obesity. For example, hypothalamic pro-opiomelanocortin
neurons, which are involved in the regulation of food intake,
are progressively silenced during aging (Yang et al., 2012).
Most of the knowledge on fat development stems from experi-
mental studies in which white adipose tissue (WAT) expansion
occurs rapidly upon high-fat diet (HFD) feeding. The mecha-
nisms involved in progressive WAT expansion during aging,
however, remain mostly unidentified. Because obesity at a later
age predisposes to life-threatening conditions such as insulin
resistance, type 2 diabetes, and cardiovascular disease, under-
standing the causal molecular mechanisms of age-related
obesity may provide a strategy for treating these disorders.
One of the hallmarks of aging is the functional dysregulation of
mitochondria (Lo´pez-Otı´n et al., 2013), which constitute the
central metabolic hub in many cell types and are the gateway
to aerobic metabolism. Mitochondrial oxidative phosphorylation
is governed by the electron transport chain (ETC). Oxygen is therts 16, 2991–3002, September 13, 2016 ª 2016 The Authors. 2991
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
final electron acceptor in the ETC, and cytochrome c oxidase
(complex IV [CIV]), the terminal enzyme of the ETC, reduces it
to H2O after which energy is produced in the form of ATP by
the action of ATP synthase (Saraste, 1999). In mature white ad-
ipocytes, mitochondria have a central role in many processes,
such as ensuring energy generation through fatty acid b-oxida-
tion in the mitochondrial matrix (Kusminski and Scherer, 2012;
Villarroya et al., 2009). Aside from ATP production, mitochondria
generate the necessary metabolic intermediates for lipid synthe-
sis, thereby determining lipogenic potential (Kusminski and
Scherer, 2012). Moreover, mitochondrial activity in WAT is
associated with the release of several adipokines, including
adiponectin (Kim et al., 2007; Koh et al., 2007; Kusminski and
Scherer, 2012).
Aging has also been associated with increased adiposity early
in the lives of mice and humans (Gargiulo et al., 2014; Kuk et al.,
2009). However, it is unclear whether mitochondrial dysfunction
in WAT contributes to age-related adipocyte enlargement and
whether it can be restored to counteract age-dependent WAT
expansion. Here we report that adipocytes of early middle-
aged mice already exhibit mitochondrial dysfunction, which is
largely associated with a decline of mitochondrial CIV activity
and assembly. This decline in CIV activity involves a hypoxia-
inducible factor 1A (HIF1A)-dependent reduction of CIV compo-
nents, including cytochrome c oxidase subunit Vb (Cox5b).
Silencing of Cox5b is sufficient to promote a global decline of
CIV assembly, as well as decreased fat oxidation, and contrib-
utes to adipocyte enlargement during aging. Conversely, in vivo
restoration of COX5B expression counteracts age-dependent
white adipocyte enlargement. Collectively, our findings highlight
the potential of targeting mitochondrial CIV to reverse adipocyte
expansion during aging.
RESULTS
Selective Reduction of White Adipocyte Mitochondrial
CIV Activity during Age-Dependent Obesity
During aging, mouse body weight progressively increased from
31.7 ± 1.2 g (in 3- to 5-month-old mice) to 43.3 ± 3.7 g (8- to
11-month-old mice), indicating that molecular mechanisms
involved in age-dependent body weight gain are initiated early
in life. We therefore focused the study on those initiating events
of obesity in early middle-aged mice rather than in older mice.
Throughout this work, 3- to 5-month-old mice are called
‘‘young’’ mice and 8- to 11-month-old mice are termed ‘‘aging’’
mice. We used the term ‘‘aging’’ instead of ‘‘aged’’ or ‘‘old’’ in
this context to denote the process of progressively getting
older. Age-dependent weight gain was accompanied by a sig-
nificant increase in the size of adipocytes from epididymal WAT
(eWAT) (Figures 1A, 1B, and S1), a visceral WAT depot with a
remarkable expansion capacity during aging and a major risk
factor for metabolic disease (Rosen and Spiegelman, 2014).
To investigate the molecular mechanisms underlying age-
dependent WAT enlargement, we focused on mitochondria
because of their emerging fundamental role in white adipocyte
biology (Bournat and Brown, 2010; Kusminski and Scherer,
2012; Rosen and Spiegelman, 2014; Villarroya et al., 2009)
and in aging (Lo´pez-Otı´n et al., 2013). Although mitochondrial2992 Cell Reports 16, 2991–3002, September 13, 2016content of eWAT adipocytes was similar between young and
aging mice (Figure 1C), the oxygen consumption rate (OCR)
and ATP turnover were significantly lower in eWAT of aging
mice (Figures 1D and 1E). More detailed mitochondrial activity
analysis revealed a significant decline of CIV activity in aging
white adipocytes, whereas complex I, II, I+III, and II+III activities
remained unchanged (Figure 1F). Furthermore, western blot
analysis showed that the protein levels of representative CIV
subunits, such as COX5B, NDUFA4, and mt-CO1, were signif-
icantly lower in aging than in young adipocytes (Figures 1G and
1H). By contrast, protein expression levels of NADH dehydro-
genase (ubiquinone) 1 alpha subcomplex 9 (NDUFA9; complex
I), succinate dehydrogenase complex, subunit A, flavoprotein
(Fp) (SDHA; complex II), ubiquinol-cytochrome c reductase
core protein 1 (UQCRC1; complex III), and mitochondrial
voltage-dependent anion channel 1 (VDAC1) were not signifi-
cantly changed (Figures 1G and 1H). These data show that
while mitochondrial oxygen consumption is reduced in aging
eWAT, not all mitochondrial complexes are equally affected
during this process, and mitochondrial CIV is specifically
repressed.
HIF1A Promotes Age-Dependent eWAT Expansion and a
Reduction of CIV Expression
To investigate the molecular mechanisms involved in age-
dependent regulation of mitochondrial CIV and adipocyte
enlargement, we focused on HIF1A because previous studies
have demonstrated its activation in aged tissues (Gomes et al.,
2013; Gonza´lez-Rodrı´guez et al., 2012). Although these studies
were performed at later stages during the lifespan of the mouse,
we wondered whether HIF1A is already expressed in WAT of
aging mice (8- to 11-month-old mice). Western blot analysis
confirmed that the steady-state levels of HIF1A in eWAT were
higher in aging than in young mice (Figure 2A), and this was
not seen in other tissues, such as brown adipose tissue or liver
(Figure S2A). We therefore questioned whether HIF1A could
drive age-dependent white adipocyte enlargement. To do this,
we generated mice with global or adipocyte-restricted Hif1a
gene deficiency using transgenic mice expressing ubiquitin-
Cre-ERT2 (Hif1aDUbq) or adiponectin-Cre-ERT2 (Hif1aDAdipo),
respectively (Figures S2B and S2F). Aging Hif1aDUbq and
Hif1aDAdipo mice gained significantly less body weight (Figures
S2D, S2E, S2G, and S2H) and had smaller eWAT adipocytes
(Figures 2B, 2C, and S2C) under normal dietary conditions
than aging control mice, suggesting that adipocyte HIF1A drives
age-dependent obesity.
Given that HIF1A functions as a transcription factor that can
also be involved in gene repression (Eltzschig et al., 2005;
Gordan et al., 2007; Krishnan et al., 2012), we next evaluated
the possibility that the expression of nuclear-encoded CIV
gene transcripts was repressed in aging adipocytes in a
HIF1A-dependent manner. By RT-PCR analysis, we found
that the levels of Cox5b, Cox6a, Cox6c, and Cox8a mRNA
were all significantly lower in aging adipocytes than in young
adipocytes, whereas the mRNA expression level of other
CIV subunits was unaffected (Figure S2I). In addition, only
Cox5b and Cox8a mRNA levels were restored in Hif1a-defi-
cient adipocytes (Figure 2D). Only a few CIV genes were
Figure 1. Mitochondrial CIV Activity Is Spe-
cifically Decreased during Age-Dependent
Obesity in White Adipocytes
(A and B) Average adipocyte area (A) and adipocyte
size frequency (B) distribution in young mice (n = 7)
and aging mice (n = 5).
(C) Mitochondrial content in isolated white adipo-
cytes of young mice (n = 4) and aging mice (n = 5).
(D) Mitochondrial OCR in eWAT from young mice
(n = 6) and aging mice (n = 7). OCR was measured
after sequential addition of glutamate and malate
(Glut + Mal, State 4), ADP (Glut + Mal, State 3),
succinate (Glut + Mal + Succ, State 3), and oligo-
mycin (Glut + Mal + Succ, State 4).
(E)Mitochondrial OCRcoupled to ATP synthesis (or
ATP turnover) in eWAT from young mice (n = 6) and
aging mice (n = 7).
(F) Activities of the indicated mitochondrial ETC
complexes were measured in isolated white
adipocytes of young mice (n = 6) and aging mice
(n = 10).
(G and H) Western blot analysis (G) and quantifi-
cation of the indicatedmitochondrial subunits (H) in
isolated white adipocytes of young mice (n = 12)
and aging mice (n = 10). Protein expression was
normalized to VDAC1.
In bar graphs, values represent mean ± SEM (error
bars). In box and whiskers plots, vertical lines
connect the minimum and the maximum values.
Statistical significance was assessed with a
two-tailed t test (*p < 0.05; **p < 0.01; ***p < 0.001;
NS, not significant). See also Figure S1.affected by aging, which was surprising because our analysis
of protein content of other representative subunits, such as
NDUFA4 or mt-CO1 (Figures 1G and 1H), indicated a more
global repression in aging adipocytes. The protein content of
NDUFA4 and mt-CO1 was restored by Hif1a deletion (Fig-
ure 2E), suggesting that HIF1A-dependent repression of
Cox5b and Cox8a mRNAs could lead to reduced protein con-
tent of other mitochondrial CIV subunits in aging adipocytes.
In this respect, it has been previously shown in a macrophage
cell line that Cox5b silencing is sufficient to promote global
CIV dysfunction by reducing the protein stability of other CIVCell Reportscomponents (Galati et al., 2009). To
test whether COX5B and COX8A control
CIV stability in adipocytes, we silenced
both in 3T3-L1 cells (Figure 3A) and
found reduced protein levels of the mito-
chondrial CIV subunits NDUFA4 and
mt-CO1 (Figure 3B). Moreover, silencing
of Cox5b resulted in a profound decline
of both CIV activity and CIV assembly
(Figures 3C and 3D). The ability of
COX5B to regulate CIV stability was
dose dependent, because silencing
Cox5b by 90% (as occurred in clone
#2) resulted in a stronger inhibition of
CIV assembly and activity than that
observed when Cox5b was reduced by60%–70% (as occurred in clone #1) (Figures 3C and 3D). In
addition, robust silencing of Cox8a mRNA (90%–95%)
reduced mitochondrial CIV activity and assembly, but to a
lesser extent than that observed for Cox5b silencing (Figures
3C and 3D). In agreement with these data, CIV assembly
was also reduced in aging adipocytes (Figures 3E and 3F).
Collectively, these data show a global decline of CIV in aging
white adipocytes that is characterized by repression of CIV
activity and assembly. This CIV dysfunction could be initiated
by repressing Cox5b, as well as Cox8a, through HIF1A stabiliza-
tion during WAT expansion.16, 2991–3002, September 13, 2016 2993
Figure 2. HIF1A Promotes Age-Dependent
Complex IV Decline Associated with eWAT
Expansion
(A) Representative western blot analysis and
quantification of HIF1A in eWAT from young and
aging mice.
(B) Average adipocyte size in Hif1aDAdipo mice (n =
6) andHif1afloxed control mice (n = 8) at the age of 8–
10 months.
(C) Adipocyte area frequency distribution analysis
in Hif1aDAdipo mice (n = 6) and control mice (n = 8) at
the age of 8–10 months.
(D) mRNA expression levels of Cox5b, Cox8a,
Cox6c, and Cox6a1 in isolated adipocytes of Hi-
f1aDAdipo mice (n = 6) and Hif1afloxed control mice
(n = 5) at the age of 8–10 months.
(E) Western blot analysis of CIV subunits (COX5B,
NDUFA4, and mt-CO1) in isolated adipocytes of
Hif1aDUbq mice and control mice (control).
In bar graphs, values represent mean ± SEM (error
bars). In box and whiskers plots, vertical lines
connect the minimum and the maximum values.
Statistical significance was assessed with a two-
tailed t test (*p < 0.05; **p < 0.01; ***p < 0.001; NS,
not significant). See also Figure S2.HIF1A Binds the Cox5b Proximal Promoter
We next examined the molecular link between HIF1A and CIV
gene expression, focusing our analysis on Cox5b and Cox8a.
Previous studies have reported a HIF1A-dependent repression
of some genes following the binding of HIF1A to their DNA regu-
latory regions (Eltzschig et al., 2005; Krishnan et al., 2012). We
therefore first assessed the presence of HIF1A binding activity
in the DNA regulatory regions of Cox5b and Cox8a (Dhar et al.,
2008). Sequence analysis revealed potential HIF1A binding sites
from 93 to 97 positions (Figure 4A) and from 760 to 756
positions (Figure S3A) of murine Cox5b and Cox8a DNA regula-
tory regions, respectively. Chromatin immunoprecipitation
(ChIP) using an anti-HIF1A antibody confirmed the binding of
HIF1A to the Cox5b proximal promoter region in 3T3-L1 cells
exposed to hypoxia (Figure 4B). Moreover, binding of HIF1A
was specific to this region, because it was not detected with
oligonucleotides directed to amplify a distal region of the
Cox5b promoter or the Cox8a proximal promoter (Figures 4A,
4B, S3A, and S3B). Consistent with HIF1A binding to this region,
expression of Cox5bmRNA was significantly reduced in 3T3-L1
cells under hypoxia (Figure 4C), whereas the mRNA of the prolyl
hydroxylase domain enzyme 3 (Phd3), a well-characterized HIF-
inducible gene, was increased (Figure S3C). To validate the role
of HIF1A in Cox5b gene repression, we used Hif1a-deficient
murine embryonic fibroblasts (MEFs). We first confirmed that
repression of Cox5b gene expression occurred in wild-type
MEF exposed to hypoxia (Figure 4D), whereas Phd3 expression2994 Cell Reports 16, 2991–3002, September 13, 2016was elevated (Figure S3D). Moreover,
activation of the HIF pathway with
dimethyloxaloylglycine (DMOG), a com-
petitive inhibitor of prolyl hydroxylase
oxygen sensors, reduced Cox5b gene
expression in MEF (Figure 4E). As ex-pected, Cox5b gene repression by hypoxia or DMOG treatment
was markedly attenuated in Hif1a-deficient MEF (Figures 4D
and 4E), strongly suggesting that HIF1A acts as a transcriptional
repressor of Cox5b. As a positive control, the expression of
Phd3 was less evident in Hif1a-deficient MEF (Figures S3D
and S3E).
Overall, these data indicate thatCox5b repression is a primary
event that occurs upon HIF1A stabilization in aging adipocytes.
We therefore further explored the role of CIV in the control of
adipocyte size during aging by modifying white adipocyte
COX5B expression.
Mitochondrial CIV Inhibition through Silencing of Cox5b
Promotes Intracellular Lipid Accumulation and White
Adipocyte Enlargement
We next determined whether COX5B-dependent mitochondrial
CIV repression controls lipid accumulation and age-dependent
adipocyte size enlargement. To evaluate intracellular lipid accu-
mulation, 3T3-L1-shCOX5B (small hairpin COX5B RNA) cells
and control cells were stained with Nile red and intracellular
lipids were measured by flow cytometry. Lipid content was
higher in 3T3-L1-shCOX5B cells than in control cells (Figures
5A and S4A), suggesting that a reduction in CIV activity
by Cox5b silencing is sufficient to promote lipid storage. To
confirm this finding, 3T3-L1-shSCR (small hairpin scrambled
RNA) control cells were treated with sodium azide, a well-es-
tablished pharmacological inhibitor of CIV. Azide treatment
Figure 3. Comparative Analysis of Cox5b and
Cox8a Silencing Effects on CIV Activity and
Assembly
(A) Left panel: mRNA expression of Cox5b in 3T3-
L1-shCOX5B cells using two shRNA sequences:
clone 1 (#1) and clone 2 (#2) relative to 3T3-L1-
shSCR control cells (n = 4 independent experi-
ments). Right panel: mRNA expression of Cox8a
in 3T3-L1-shCOX8A cells using two shRNA se-
quences: clone 1 (#1) and clone 2 (#2) relative to
3T3-L1-pLKO control cells (n = 3 independent
experiments).
(B) Western blot analysis of the indicated mito-
chondrial ETC subunits in 3T3-L1-shCOX5B and
3T3-L1-shCOX8A cells and their respective
controls.
(C) CIV activity in 3T3-L1-shCOX5B cells and 3T3-
L1-shCOX8A cells and their respective controls.
(D) Blue native-PAGE western blot analysis showing
mitochondrial complexes and super-complexes in
3T3-L1-shCOX5B and 3T3-L1-shCOX8A cells
and their respective controls. UQCRC2 or mt-CO1
antibody was used to identify complex III or IV
assembly.
(E and F) Representative images (E) and quantifica-
tion (F) of blue native-PAGE analysis of mitochon-
drial complex III and IV assembly using UQCRC2 or
mt-CO1, respectively, in isolated adipocytes of
young mice (n = 8) and aging mice (n = 8).
In bar graphs, values represent mean ± SEM (error
bars). Statistical significance was assessed with a
two-tailed t test (*p < 0.05; **p < 0.01; ***p < 0.001;
NS, not significant).also increased the Nile red signal intensity in 3T3-L1-shSCR
control cells (Figure 5A). Because increased fat accumulation
has been associated with reduced fatty acid oxidation (Kusmin-
ski and Scherer, 2012; Vernochet et al., 2012), we also
measured fatty acid oxidation in Cox5b-silenced cells. Both
3T3-L1-shCOX5B cells and azide-treated 3T3-L1-shSCR cells
presented significantly reduced fatty acid oxidation when
compared with control cells (Figure 5B). Furthermore, consis-
tent with aging adipocytes, Cox5b silencing in 3T3-L1 cells
reduced oxygen consumption and ATP turnover (Figures 5C,
5D, S4B, and S4C). Collectively, these data suggest that
repression of Cox5b leads to the attenuation of mitochondrial
CIV activity, which is sufficient to reduce fatty acid oxidation
and promote intracellular lipid accumulation.
We next asked whether Cox5b silencing in young mice would
promote white adipocyte enlargement in vivo. We therefore in-
jected lentiviral shCOX5B particles into the right eWAT depot
of young wild-type mice, while the left contralateral eWAT depot
remained uninjected and served as an internal control (Fig-
ure 6A). An identical protocol was used for control shSCR parti-
cles (Figure 6A). Injection of shCOX5B particles significantlyCell Reportreduced the ratio of Cox5b mRNA levels
in the injected to non-injected eWAT depot
when compared with shSCR mice (Fig-
ure 6B), which was concomitant with a
significant increase in the adipocyte sizeratio (Figure 6C). Moreover, analysis of adipocyte size distribu-
tion revealed that shCOX5B-injected eWAT depots contained a
greater proportion of large adipocytes and a smaller proportion
of small adipocytes than shSCR-injected depots (Figure 6D).
No significant differences were found in the contralateral non-in-
jected depots (Figure S5A). Thus, the reduction of COX5B
expression in the eWAT of young mice drives white adipocyte
enlargement, indicating that Cox5b repression is an important
determinant of eWAT adipocyte size.
In vivo COX5B Restoration Attenuates Adipocyte Size
Enlargement in Aging Mice
These findings prompted us to evaluate whether restoration of
COX5B expression could be exploited as a potential molecular
target to prevent age-dependent adipocyte enlargement. To
do this, we first validated that overexpression of COX5B protein
is sufficient to increase mitochondrial CIV activity. Ectopic over-
expression of COX5B protein in HEK293T cells (Figure S5B)
increased mitochondrial CIV activity (Figure S5C). Next, lentiviral
particles overexpressing COX5B were injected into the right
eWAT depot of aging mice, while the left contralateral viscerals 16, 2991–3002, September 13, 2016 2995
Figure 4. HIF1A Binds to theCox5b Proximal
Promoter
(A) Schematic representation of the mouse Cox5b
gene and its promoter region, indicating the posi-
tion of the HIF1A binding site in bold.
(B) ChIP assay to assess the relative HIF1A binding
activity to themouseCox5b proximal promoter and
distal region in 3T3-L1 cells exposed to normoxia
or hypoxia 0.5% for 18–20 hr (n = 7 independent
experiments). A representative gel showing DNA
amplified in the ChIP assays is shown in the lower
panel.
(C) Cox5b mRNA expression levels in 3T3-L1 cells
exposed to normoxia or hypoxia 0.5% for 72 hr
(n = 4 independent experiments).
(D) Cox5b mRNA expression levels in control or
Hif1afl/fl MEF exposed to normoxia or hypoxia
0.5% for 48 hr (n = 4 independent experiments).
(E) Cox5b mRNA expression levels in control or
Hif1afl/fl MEF under normoxia or 48 hr after 0.5 mM
DMOG treatment (n = 4 independent experiments).
In bar graphs, values represent mean ± SEM (error
bars). Statistical significance was assessed with a
two-tailed t test (*p < 0.05; **p < 0.01). See also
Figure S3.eWAT depot remained uninjected (Figure 6E). An identical
protocol was used for control empty vector particles (Figure 6E).
Injection of COX5B-expressing lentiviral particles significantly
increased the ratio of Cox5b mRNA levels in the injected to
non-injected eWAT depot when compared with empty vector
mice (Figure 6F) and significantly decreased the adipocyte size
(Figure 6G). Adipocyte size distribution analysis revealed a
greater proportion of small adipocytes and a reduced proportion
of large adipocytes in COX5B-injected eWAT depots when
compared with the empty vector-injected eWAT depots (Fig-
ure 6H), whereas no significant differences were observed in
the corresponding non-injected contralateral eWAT depots
(Figure S5D).
These in vivo data demonstrate that restoring COX5B expres-
sion in visceral eWAT is sufficient to attenuate adipocyte
enlargement in aging mice, underscoring the relevance of
COX5B to control age-dependent adipocyte size.2996 Cell Reports 16, 2991–3002, September 13, 2016Human WAT COX5B Expression
Correlates Negatively with Age and
Serves as a Prognostic Factor for
Weight Loss after Bariatric Surgery
Finally, to explore the potential relevance
of our findings in humans, we measured
COX5B expression in human visceral adi-
pose tissue (VAT) during aging in a cohort
of subjects with a range of adiposity
(anthropometric and clinical parameters
are described in the Experimental Proced-
ures section). We found that COX5B
mRNA levels correlated negatively with
age in this cohort (Figure 7A), which per-
sisted after controlling for BMI in multiple
linear regression analysis (Figure 7B).Expression of the mitochondrial marker VDAC1 was not associ-
ated with age in this cohort (Figures 7C and 7D), suggesting that
the decrease in COX5B expression was not attributable to an
overall decrease in the expression ofmitochondrial components.
Thus, the expression of COX5B is highly vulnerable to visceral
WAT aging, not only in mice but also in human VAT.
We also investigated the clinical value of our findings. Post-
bariatric surgery weight reduction shows great disparities
among individuals (Lutfi et al., 2006; Maggard et al., 2005), and
age has been shown to be a prognostic factor (Scozzari et al.,
2012). We therefore asked whetherCOX5B in WATmight predict
long-term weight loss in humans after bariatric surgery. We
found that subcutaneous white adipose tissue (SAT) COX5B
levels negatively correlated with BMI 1 year after bariatric
surgery (Figure 7E), whereas VDAC1 showed the opposite
trend (Figure 7F). Patients with higher COX5B levels had a lower
BMI 1 year after bariatric surgery (Figure 7E), underlining the
Figure 5. Mitochondrial CIV Inhibition and
Cox5b Silencing Results in Intracellular Lipid
Storage In Vitro and Decreases Mitochon-
drial Respiration
(A) Nile red fluorescence intensity in 3T3-L1-
shCOX5B #2 cells, 3T3-L1-shSCR control cells,
and 3T3-L1-shSCR control cells treated with 5 mM
azide. A representative experiment out of seven
independent experiments is shown.
(B) Fatty acid oxidation in 3T3-L1-shCOX5B #2
cells (n = 6), 3T3-L1-shSCR control cells (n = 5), and
3T3-L1-shSCR control cells treated with 5 mM
azide (n = 6).
(C) Mitochondrial OCR in 3T3-L1-shCOX5B #2
cells, 3T3-L1-shSCR control cells, and 3T3-L1-
shSCR control cells treated with 5mMazide (n = 6).
(D) ATP turnover in 3T3-L1-shCOX5B #2 cells, 3T3-
L1-shSCR control cells, and 3T3-L1-shSCR control
cells treated with 5 mM azide (n = 6).
In bar graphs, values represent mean ± SEM (error
bars). Statistical significance was assessed with a
two-tailed t test (*p < 0.05; **p < 0.01; ***p < 0.001).
See also Figure S4.translational relevance and clinical value of COX5B measure-
ments in SAT. Moreover, SAT samples can be gathered using
a minimally invasive biopsy technique (Campbell et al., 2009),
which also supports the clinical relevance of measuring COX5B.
Overall, our data show that repression of mitochondrial CIV
activity is an early sign of age-dependent mitochondrial dysfunc-
tion in white adipocytes that drivesWAT expansion during aging.
Moreover, these data highlight the potential of CIV restoration to
prevent increased adipocyte size enlargement during aging.
DISCUSSION
Aging is associated with increased adiposity early in life (Gar-
giulo et al., 2014; Kuk et al., 2009), suggesting that the molecular
mechanisms underlying age-dependent WAT expansion should
be initiated at an early stage of the lifetime. This is in contrast to
other molecular alterations associated with aging, which are
usually studied in very old mice (22- to 30-month-old mice)
(Gomes et al., 2013; Houtkooper et al., 2011). Our study shows
that mitochondrial CIV activity is specifically compromised in
white adipocytes in early phases during aging (8- to 11-month-
old mice), although the activity of other mitochondrial com-
plexes, as well as mitochondrial content, are unaltered. There-
fore, our study identifies WAT CIV dysfunction as an early sign
of aging in white adipocytes that manifests in middle-aged
mice, which leads to progressive age-dependent body weight
gain during the lifetime.
Previous studies have demonstrated that mitochondrial activ-
ity is globally repressed in more severe models of obesity.
Accordingly, mice subjected to HFD and mice with altered leptin
signaling, such as ob/ob and db/db mice, show a significant
decline in mitochondrial content in WAT (Choo et al., 2006;
Rong et al., 2007; Sutherland et al., 2008; Valerio et al., 2006).
It is possible that these settings, which are different from age-dependent obesity, have specific features that provoke global
mitochondrial dysfunction in white adipocytes. The reasons for
these differences are unclear, but one possible explanation is
the excessive nutrient supply in HFD models. Several studies
have shown that high levels of nutrients, including free fatty
acids, lead to global mitochondrial dysfunction through diverse
mechanisms, including oxidative stress and production of in-
flammatory cytokines (Gao et al., 2010; Kusminski and Scherer,
2012; Sutherland et al., 2008; Valerio et al., 2006). It is therefore
conceivable that global mitochondrial dysfunction, including a
decrease in mitochondrial content, is a general response to a
pathological WAT scenario that is more characterized by nutrient
overload. Presumably, this nutrient surplus occurs to a lesser de-
gree, or maybe absent, during age-dependent WAT expansion.
Along this line, human studies have shown that mitochondrial
content is not consistently repressed in obese subjects (Kaaman
et al., 2007; Lindinger et al., 2010; Yin et al., 2014). Lindinger et al.
(2010) described a trend for reduced mtDNA content in diabetic
obese patients but not in non-diabetic obese patients. In this re-
gard, our present data in human VAT show that the expression of
the mitochondrial marker VDAC1 is not affected during aging,
whereas the expression of COX5B is significantly repressed,
indicating that aging can promote specific mitochondrial alter-
ations in VAT. Furthermore, we show the prognostic potential
of COX5B measurements in WAT, because patients with higher
COX5B levels have lower BMI 1 year after bariatric surgery.
These data are in accordance with a study showing that younger
patients experienced a significantly greater and prolonged BMI
decrease after surgery (Scozzari et al., 2012).
Previous studies have detected hypoxia in WAT under normal
dietary conditions, based on pimonidazole staining (Hosogai
et al., 2007; Lee et al., 2011; Ye et al., 2007). These data might
explain the basal HIF1A expression observed in WAT of young
mice (Figure 2A) (Krishnan et al., 2012; Lee et al., 2014; YinCell Reports 16, 2991–3002, September 13, 2016 2997
Figure 6. Opposing Effects of In Vivo
Silencing and Restoration of Cox5b Expres-
sion in eWAT
(A) Schematic representation of eWAT injection of
shSCR and shCOX5B lentiviral particles in mice.
(B) Ratio of Cox5b mRNA expression levels in in-
jected to non-injected eWAT depots of shCOX5B
mice (n = 4) and shSCR mice (n = 4). Fold change
relative to shSCR is shown.
(C) Ratio of average adipocyte size in injected to
non-injected eWAT depot of shCOX5B mice (n = 4)
and shSCR mice (n = 4). Fold change relative to
shSCR is shown.
(D) Adipocyte area frequency distribution analysis
in shCOX5B (n = 4) and shSCR (n = 4) injected
depots.
(E) Schematic representation of eWAT injection of
COX5B and empty vector lentiviral particles in
mice.
(F) Ratio of Cox5b mRNA expression in injected to
non-injected eWAT depot of COX5B mice (n = 4)
and empty vector mice (n = 5). Fold change relative
to empty vector is shown.
(G) Ratio of average adipocyte size in injected to
non-injected eWAT depots of COX5B mice (n = 4)
and empty vector mice (n = 4). Fold change relative
to empty vector is shown.
(H) Adipocyte area frequency distribution analysis
in COX5B (n = 4) and empty vector (n = 4) injected
depots.
In bar graphs, values represent mean ± SEM (error
bars). Statistical significance was assessed with a
two-tailed t test (*p < 0.05; **p < 0.01). See also
Figure S5.et al., 2009), which drives CIV repression and subsequent fat
accumulation during aging. This latter contention is in line with
a previous study showing that adipocyte-restricted inactivation
of Arnt, a transcription factor with multiple partners, including
HIF1A, counteracts age-dependent body weight gain (Lee
et al., 2011). In addition, adipocyte-restricted Hif1a gene inacti-
vation counteracts pathological WAT expansion in HFD-fed
mice (Jiang et al., 2011; Krishnan et al., 2012; Lee et al., 2011,
2014). Regarding the molecular mechanisms executed by
HIF1A leading to age-dependent white adipocyte enlargement,
we found that HIF1A represses Cox5b and Cox8a gene expres-
sion. Previous studies have reported HIF1A-dependent gene
repression associated with the binding of HIF1A to DNA regula-
tory regions of target genes (Eltzschig et al., 2005; Krishnan et al.,
2012). In the present study, we found that hypoxia inducesHIF1A
binding to the Cox5b proximal promoter, which was associated2998 Cell Reports 16, 2991–3002, September 13, 2016with Cox5b repression. This promoter re-
gion has been previously shown to sustain
Cox5b gene expression through NRF1
transcription factors (Dhar et al., 2008),
suggesting that HIF1A could interfere
with its basal activity. By contrast,
although we acknowledge that HIF1A-
dependent Cox8a repression can poten-
tially cooperate with Cox5b to reduceCIV activity in aging adipocytes, we did not find HIF1A binding
activity at the Cox8a proximal promoter, suggesting that HIF1A
could drive Cox8a repression by indirect mechanisms, as
described for other target genes repressed by HIF1A (Chan
et al., 2009). Our analysis also shows that Cox6a and Cox6c
expression in white adipocytes declined during age-dependent
body weight gain but was not restored upon Hif1a deletion in
aging adipocytes, suggesting that their regulation is executed
by other hypoxia-dependent pathways (Sena and Chandel,
2012) or as a consequence of fat accumulation (Lee et al.,
2014). A previous study has shown that HIF1A induces a
COX4.2/COX4.1 switch to protect cells against hypoxia-induced
reactive oxygen species (ROS) by optimizing respiration effi-
ciency (Fukuda et al., 2007). However, we have not found evi-
dence of this metabolic adaptation in aging WAT, suggesting
that perhaps this switch is not operative in white adipocytes or
Figure 7. Age-Dependent Repression of COX5B Gene Expression in Human VAT and COX5B as a Prognostic Factor in Bariatric Surgery
(A–D) Boxplots showing log COX5B (A) or VDAC (C) gene expression in human VAT with increasing age quartiles (see Experimental Procedures); vertical lines
connect the minimum and the maximum values (n = 24). Linear correlation analysis of the association between COX5B (B) or VDAC (D) gene expression in human
VAT and age. Results remained significant after adjusting for Deuremberg-calculated fat mass instead of BMI.
(E and F) Linear correlation analysis of the association between COX5B (E) or VDAC (F) gene expression in human subcutaneous white adipose tissue (SAT) and
BMI 1 year after bariatric surgery (n = 31).
Differences in human gene expression across age quartiles were evaluated with one-way ANOVA (*p < 0.05; NS, not significant). Linear association between gene
expression and age or BMI was evaluated with Spearman’s rank test.
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it requires a more robust activation of HIF1A than that observed
in aging adipocytes in vivo. Collectively, our data suggest that
HIF1A-dependent repression of Cox5b expression can be
considered a primary event, leading to a more global CIV decline
because of the central role of COX5B in CIV stability, and further
establish a molecular link between HIF1A and CIV, wherein
HIF1A acts as a global repressor of CIV expression in white
adipocytes.
Adipocyte-restricted inactivation and overexpression of key
genes involved in mitochondrial biogenesis and activity is funda-
mental to better understand the role ofmitochondria in adipocyte
biology. It has been hypothesized that inactivation of these
genes would reduce mitochondrial activity, leading to intracel-
lular accumulation of lipids that cannot be oxidized (Kusminski
et al., 2012; Vernochet et al., 2012, 2014). For example, reduced
adipocyte mitochondrial activity and increased adipocyte size
was detected in mice with adipose tissue-restricted overexpres-
sion of mitoNEET, an iron-sulfur protein that inhibits mitochon-
drial iron transport into the matrix and lowers the rate of b-oxida-
tion (Kusminski et al., 2012). However, other studies have shown
that adipocyte-restricted inactivation of the mitochondrial tran-
scription factor A (TFAM), which is essential for maintenance of
mtDNA, does not lead to increased adiposity because of an
unanticipated compensatory response leading to increased
mitochondrial oxygen consumption and uncoupling (Vernochet
et al., 2012). Moreover, a second mouse model in which Tfam
was inactivated in adipose tissue to a greater extent revealed a
profound and global dysfunction of mitochondria, resulting in
adipocyte death and subsequent lipodystrophy (Vernochet
et al., 2014). In contrast to these studies, our data indicate that
mitochondrial CIV dysfunction through Cox5b repression is suf-
ficient to drive intracellular lipid accumulation. Our data suggest
that a decline in COX5B protein content cannot be followed by
compensatory mitochondrial overactivation or adipocyte death
and culminates in enhanced adipocyte lipid content. Therefore,
it is possible that during age-dependent body weight gain,
repression of Cox5b guarantees enhanced lipid storage without
these secondary compensatory effects on mitochondrial activity
or adipocyte death.
In summary, our data establish mitochondrial CIV, and partic-
ularly COX5B, as a vulnerable mitochondrial component during
visceral WAT aging in mice and humans. Cox5b repression is
mediated by the HIF1A pathway and is sufficient to promote
age-dependent white adipocyte enlargement. Moreover, our
findings highlight the potential of COX5B restoration in visceral
WAT to counteract age-dependent adipocyte expansion.EXPERIMENTAL PROCEDURES
White Adipocyte Isolation
Epididymal fat pads were removed, minced, and digested using collagenase
type II (Calbiochem) at 37C for 1 hr in Krebs-Ringer-HEPES-bicarbonate
(KRH) buffer supplemented with BSA (3.5%; Roche). The digested tissue
was filtered through a 100 mm cell strainer (BD Falcon), and the floating adipo-
cytes were recovered and used for RNA or protein extraction.
Mitochondrial Content
Relative concentrations of nuclear DNA and mtDNA were determined by
RT-PCR. In brief, DNA was isolated from adipocytes using UltraPure phenol:3000 Cell Reports 16, 2991–3002, September 13, 2016chlorofom:isoamyl alcohol (25:24:1; Invitrogen) after proteinase K (Ambion)
digestion at 56C overnight. Nuclear DNA and mtDNA were measured using
a Power SYBRGreen PCRMaster Mix kit (Applied Biosystems). The amplifica-
tion data were analyzed using StepOne Software v.2.0 (Applied Biosystems).
The following primer sets were used: Genomic Hprt: forward 50-TGGGAGGC
CATCACATTGT-30; reverse 50-TCCAGCAGGTCAGCAAAGAA-30. Genomic
mt-Co1: forward 50-GCTAGCCGCAGGCATTACTATAC-30; reverse 50-GCG
GGATCAAAGAAAGTTGTG-30.
Viral Injection In Vivo
Micewere anesthetized by isoflurane (Abbott) before dissection of the skin and
body wall. The lentiviral preparation (1 3 107–8 plaque-forming units in a
volume of 100 ml) was injected into the right eWAT depot distributed in four
to six injections of 20–25 ml (each mouse was injected with 100–150 ml of
lentiviral preparation). The left contralateral eWAT depot remained uninjected
and served as an internal control. Separate mice were injected with different
lentiviral particles. Mice injected with virus containing small hairpin RNA
(shRNA) against Cox5b were sacrificed 2–3 weeks after surgery, and the tis-
sues of interest were removed. Mice injected with virus containing overex-
pressing COX5B were sacrificed 5–6 weeks after surgery, and the tissues of
interest were removed. Mice were randomly allocated to the treatment groups
(shSCR group versus shCOX5B group, as well as empty vector group versus
COX5B group).
Histological Analysis
Adipose tissue from eWAT depots was isolated and fixed for at least 24 hr in
4%–10% formaldehyde before embedding in paraffin. Sections (5–7 mm; Leica
RM2135 microtome) were subjected to standard H&E staining and analyzed
using CellD Olympus software (Olympus). At least 200 adipocytes per mouse
were analyzed for adipocyte surface area measurement. For adipocyte size
quantification in eWAT of injected or non-injected mice, Hif1aDAdipo or control
mice, and young or aging mice, the investigator was blinded to the group
allocation.
Statistical Analysis
Data are expressed as mean ± SEM (error bars). In box and whiskers
plots, vertical lines connect the minimum and the maximum values. All
statistical analyses were performed using GraphPad Prism software, and
differences between groups with similar variances were analyzed with a
two-tailed t test. When variances of the groups were significantly different, a
two-tailed t test with Welch’s correction was used. Differences between
variances of the groups were analyzed with the Fisher test (F-test). A p value
lower than 0.05 was considered significant: *p < 0.05, **p < 0.01, and ***p <
0.001. Differences in human gene expression factors across age quartiles
were evaluated using one-way ANOVA. Linear association between gene
expression factors and age was evaluated using Spearman’s rank test.
A multiple linear regression analysis in a stepwise procedure was used to
adjust for BMI. Deuremberg-calculated fat mass was evaluated using the
following formula: percent fat mass = 1.2 3 (BMI) + 0.23 3 (age (years)) 
10.8 3 (sex)  5.4, where sex = 0 in women and sex = 1 in men.
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